Filing Details
- Accession Number:
- 0000899243-21-036500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-17 21:48:07
- Reporting Period:
- 2021-09-15
- Accepted Time:
- 2021-09-17 21:48:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1656536 | Decibel Therapeutics Inc. | DBTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1492749 | Laurence Reid | C/O Decibel Therapeutics, Inc. 1325 Boylston Street, Suite 500 Boston MA 02215 | President And Chief Executive | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-09-15 | 10,000 | $7.64 | 25,849 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.587 to $7.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.